Table 4.
IPTW-adjusted mean difference in pre– to post–PEx treatment ppFEV1, return to ≥90% of baseline ppFEV1, and time to next PEx requiring i.v. antibiotics, by number of i.v. and inhaled antipseudomonal antibiotics
| Antibiotic Combination | Change in ppFEV1 Estimate [% (95% CI)] | P Value | Return to ≥90% of Baseline ppFEV1 [Odds Ratio (95% CI)] | P Value | Time to Next PEx [Hazard Ratio (95% CI)] | P Value |
|---|---|---|---|---|---|---|
| Two i.v. and one inhaled | −1.16 (−2.05 to −0.28) | 0.01 | 0.92 (0.79 to 1.08) | 0.30 | 1.04 (0.96 to 1.12) | 0.31 |
| One i.v. and one inhaled | −0.30 (−1.45 to 0.86) | 0.61 | 0.98 (0.78 to 1.22) | 0.84 | 1.11 (1.01 to 1.23) | 0.04 |
| One i.v. and no inhaled | −0.33 (−1.24 to 0.57) | 0.47 | 0.89 (0.75 to 1.06) | 0.20 | 1.08 (0.99 to 1.17) | 0.072 |
Definition of abbreviations: CI = confidence interval; IPTW = inverse probability of treatment weighting; i.v. = intravenous; PEx = pulmonary exacerbation; ppFEV1 = percent predicted forced expiratory volume in 1 second.
Antibiotic category reference (two i.v.; no inhaled).